Cargando…

Personality disorder and functioning in major depressive disorder: a nested study within a randomized controlled trial

OBJECTIVE: This study aimed to determine if personality disorder (PD) predicted functional outcomes in patients with major depressive disorder (MDD). METHODS: Data (n=71) from a double-blind, randomized, placebo-controlled 12-week trial assessing the efficacy of 200 mg/day adjunctive minocycline for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kavanagh, Bianca E., Williams, Lana J., Berk, Michael, Turner, Alyna, Jackson, Henry J., Mohebbi, Mohammadreza, Kanchanatawan, Buranee, Ashton, Melanie M., Ng, Chee H., Maes, Michael, Berk, Lesley, Malhi, Gin S., Dowling, Nathan, Singh, Ajeet B., Dean, Olivia M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação Brasileira de Psiquiatria 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6986492/ https://www.ncbi.nlm.nih.gov/pubmed/31116261 http://dx.doi.org/10.1590/1516-4446-2018-0308

Ejemplares similares

Protocol and Rationale-The Efficacy of Minocycline as an Adjunctive Treatment for Major Depressive Disorder: A Double Blind, Randomised, Placebo Controlled Trial
por: Dean, Olivia May, et al.
Publicado: (2014)

Adjunctive minocycline for major depressive disorder: A sub-study exploring peripheral immune-inflammatory markers and associated treatment response
por: Walker, Adam J., et al.
Publicado: (2022)

Does Post-traumatic Stress Disorder Impact Treatment Outcomes within a Randomised Controlled Trial of Mitochondrial Agents for Bipolar Depression?
por: Russell, Samantha E., et al.
Publicado: (2023)

Role of personality disorder in randomised controlled trials of pharmacological interventions for adults with mood disorders: a protocol for a systematic review and meta-analysis
por: Kavanagh, Bianca E, et al.
Publicado: (2019)

The Impact of Posttraumatic Stress Disorder on Pharmacologic Intervention Outcomes for Adults With Bipolar Disorder: A Systematic Review
por: Russell, Samantha E, et al.
Publicado: (2022)

Speaker 2: Olivia Dean, Australia
por: OM, Dean, et al.
Publicado: (2016)

Nutraceuticals and nutritional supplements for the treatment of bipolar disorder: protocol for a systematic review
por: Ashton, Melanie M, et al.
Publicado: (2019)

Minocycline for the treatment of mental health and neurological conditions: study protocol of a systematic review and meta-analysis
por: Bortolasci, Chiara C, et al.
Publicado: (2020)

A brief review of exercise, bipolar disorder, and mechanistic pathways
por: Thomson, Daniel, et al.
Publicado: (2015)

The Impact of N-acetylcysteine on Major Depression: Qualitative Observation and Mixed Methods Analysis of Participant Change during a 12-week Randomised Controlled Trial
por: Russell, Samantha E., et al.
Publicado: (2023)

A Novel Pathway Phenotype of Temporal Lobe Epilepsy and Comorbid Psychiatric Disorders: Results of Precision Nomothetic Medicine
por: Maes, Michael, et al.
Publicado: (2022)

First Episode Psychosis and Schizophrenia Are Systemic Neuro-Immune Disorders Triggered by a Biotic Stimulus in Individuals with Reduced Immune Regulation and Neuroprotection
por: Maes, Michael, et al.
Publicado: (2021)

Mixed Methods Thematic Analysis of a Randomised Controlled Trial of Adjunctive Mitochondrial Agents for Bipolar Depression
por: Russell, Samantha E., et al.
Publicado: (2022)

Influence of childhood trauma on the treatment outcomes of pharmacological and/or psychological interventions for adolescents and adults with bipolar disorder: protocol for a systematic review and meta-analysis
por: Wrobel, Anna, et al.
Publicado: (2021)

Minocycline as Treatment for Psychiatric and Neurological Conditions: A Systematic Review and Meta-Analysis
por: Panizzutti, Bruna, et al.
Publicado: (2023)

A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo
por: Berk, Michael, et al.
Publicado: (2019)

Correction to: A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo
por: Berk, Michael, et al.
Publicado: (2019)

How to Construct a Bottom-Up Nomothetic Network Model and Disclose Novel Nosological Classes by Integrating Risk Resilience and Adverse Outcome Pathways with the Phenome of Schizophrenia
por: Maes, Michael, et al.
Publicado: (2020)

The Added Burden of Personality Disorder on Subsidized Australian Health Service Utilization Among Women With Mental State Disorder
por: Kavanagh, Bianca E., et al.
Publicado: (2021)

Efficacy of adjunctive Garcinia mangostana Linn (mangosteen) pericarp for bipolar depression: study protocol for a proof-of-concept trial
por: Ashton, Melanie M., et al.
Publicado: (2018)

Cost-Utility and Cost-effectiveness of MoodSwings 2.0, an Internet-Based Self-management Program for Bipolar Disorder: Economic Evaluation Alongside a Randomized Controlled Trial
por: Chatterton, Mary Lou, et al.
Publicado: (2022)

Episodic memory and delayed recall are significantly more impaired in younger patients with deficit schizophrenia than in elderly patients with amnestic mild cognitive impairment
por: Kanchanatawan, Buranee, et al.
Publicado: (2018)

The Effect of Adjunctive Mangosteen Pericarp on Cognition in People With Schizophrenia: Secondary Analysis of a Randomized Controlled Trial
por: Marx, Wolfgang, et al.
Publicado: (2021)

Tobacco Use in Bipolar Disorder
por: Thomson, Daniel, et al.
Publicado: (2015)

Mitochondrial Agents for Bipolar Disorder
por: Pereira, Círia, et al.
Publicado: (2018)

Statin and Aspirin Use and the Risk of Mood Disorders among Men
por: Williams, Lana J., et al.
Publicado: (2016)

Lithium therapy and its interactions
por: Malhi, Gin S, et al.
Publicado: (2020)

Falls in community-dwelling women with bipolar disorder: a case–control study
por: Stuart, Amanda L., et al.
Publicado: (2022)

Protocol and Rationale: A 24-week Double-blind, Randomized, Placebo Controlled Trial of the Efficacy of Adjunctive Garcinia mangostana Linn. (Mangosteen) Pericarp for Schizophrenia
por: Turner, Alyna, et al.
Publicado: (2019)

The Therapeutic Potential of Mangosteen Pericarp as an Adjunctive Therapy for Bipolar Disorder and Schizophrenia
por: Ashton, Melanie M., et al.
Publicado: (2019)

N-Acetyl Cysteine in the Treatment of Obsessive Compulsive and Related Disorders: A Systematic Review
por: Oliver, Georgina, et al.
Publicado: (2015)

The existential crisis of bipolar II disorder
por: Gitlin, Michael, et al.
Publicado: (2020)

Evaluation of the acceptability and usefulness of an information website for caregivers of people with bipolar disorder
por: Berk, Lesley, et al.
Publicado: (2013)

Personality Disorder and Physical Health Comorbidities: A Link With Bone Health?
por: Williams, Lana J., et al.
Publicado: (2020)

Associations between personality and musculoskeletal disorders in the general population: A systematic review protocol
por: Quirk, Shae E., et al.
Publicado: (2023)

Maintenance N-acetyl cysteine treatment for bipolar disorder: A double-blind randomized placebo controlled trial
por: Berk, Michael, et al.
Publicado: (2012)

Concordance between actual and pharmacogenetic predicted desvenlafaxine dose needed to achieve remission in major depressive disorder: a 10-week open-label study
por: Bousman, Chad A., et al.
Publicado: (2017)

Coping with COVID-19: Exploring coping strategies, distress, and post-traumatic growth during the COVID-19 pandemic in Australia
por: Kavanagh, Bianca E., et al.
Publicado: (2022)

A consensus statement for safety monitoring guidelines of treatments for major depressive disorder
por: Dodd, Seetal, et al.
Publicado: (2011)

Avoidant personality disorder: current insights
por: Lampe, Lisa, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2vsaimgldvmsao2ddn9bqo4hm4